Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis-Reference-Cited by-同舟云学术

Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis

Published:2012-01 Issue:1 Volume:14 Page:60-66
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Shaheen Mohammed,Hassanain Mazen,Aljiffry Murad,Cabrera Tatiana,Chaudhury Prosanto,Simoneau Eve,Kongkaewpaisarn Nuttawut,Salman Ayat,Rivera Juan,Jamal Mohammad,Lisbona Robert,Khankan Azzam,Valenti David,Metrakos Peter

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35825 cases in the United States;Yao;J Clin Oncol,2008

2. A 5-decade analysis of 13715 carcinoid tumors;Modlin;Cancer,2003

3. Progress in the treatment of neuroendocrine tumors;Chan;Curr Oncol Rep,2009

4. Result of liver resection as treatment for metastases from noncolorectal cancer;Benevento;J Surg Oncol,2000

5. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study;Kalinowski;Digestion,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases;Journal of Pancreatology;2023-08-24

2. Association between objective response rate and overall survival in metastatic neuroendocrine tumors treated with radioembolization: a systematic literature review and regression analysis;Expert Review of Anticancer Therapy;2020-10-24

3. Liver embolisation for patients with neuroendocrine neoplasms: systematic review;Neuroendocrinology;2020-03-13

4. Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis;HPB;2019-07

5. Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization;European Radiology;2019-05-09